ImExHS (IME.AX) Stock Price

ImExHS Price

ASX·CLOSED
0.31
​
Market closed

Over the last 19 years ImExHS grew revenue by 2.5% annually, reaching 28.97 M AUD. For ImExHS, the net margin of -9.9% is up versus -35.1% a few years ago. The consensus 12-month price target for ImExHS is 0.36 AUD, about 15.2% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

ImExHS stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImExHS business model & stock analysis

ImExHS Ltd. develops and sells its Hiruko software platform, which includes modular cloud-based imaging systems for medical facilities. The medical imaging software business focuses on PACS, RIS, and Patient Portal systems that manage radiology, pathology, and other specialties. Healthcare organizations purchase these systems to capture, store, view, and share radiology images. The radiology services business provides diagnostic services to hospitals in Colombia and Spain using the company's software, while also developing AI tools through medical image analysis and radiologist reports. The company's revenue streams come from selling Hiruko software licenses and offering radiology services. Healthcare organizations in Colombia and Spain are key customers for both the software and services, with the radiology services business leveraging the software to deliver diagnostic reports and support AI development. The software's modular design allows healthcare providers to integrate workflow management, patient data, and image distribution seamlessly. ImExHS Ltd. targets healthcare organizations seeking cloud-based imaging solutions, particularly those needing PACS, RIS, and Patient Portal integration. The radiology services segment serves hospitals in Colombia and Spain, using the company's software to provide diagnostic services and generate data for AI tool development. This dual approach ensures consistent revenue from both software sales and service contracts.

Frequently asked questions about ImExHS

Analysts currently set an average price target of 0.36 AUD for the ImExHS stock (median: 0.36 AUD), implying +15.2 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the ImExHS stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect ImExHS to generate revenue of 32.85 M AUD and earnings per share of -0.00 AUD.

Converted at the current exchange rate, the ImExHS share trades at 0.19 EUR (0.31 AUD).

The ImExHS share (IME.AX) is listed on 1 stock exchanges, including: ASX (IME.AX).

The expected revenue of ImExHS is 32.85 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of ImExHS is -10,810.00 AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ImExHS is currently -1,550.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ImExHS stock.

The price-to-sales ratio (P/S) of ImExHS is currently 0.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ImExHS stock.

The Eulerpool Quality Score for ImExHS is 5/10.

The ISIN of ImExHS is AU0000023053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ImExHS is IME.AX. The ticker symbol is used to trade ImExHS shares on the stock exchange.

Fair ValueTerminal
0.26 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
96,566.86 AUD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Dec 14, 2005
ISIN
AU0000023053
Cusip
Q4857V109
Market capitalization
16.76 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-1,550.02
P/Ee 2027
43.66
P/Ee 2028
3.20
P/S
P/Se
0.51
EV/EBIT
—
P/B Ratio
1.06
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-17.54 %
Last updated Nov 19, 2026, 9:27 PM

ImExHS Peer Group

ImExHS Ticker

ASX · IME.AX

ImExHS FIGI

IME:AU · BBG000BS84K6IME:AT · BBG000BS85D1IME:AH · BBG002F3JLF9OMTEUR:EO · BBG009Q074G8OMTEUR:XH · BBG009Q074K3OMTEUR:XF · BBG009Q074M1OMTEUR:XE · BBG009Q074P8OMTEUR:XJ · BBG009Q074Q7OMTEUR:XL · BBG009Q074R6OMTEUR:XG · BBG009Q074S5OMTEUR:XO · BBG009Q074T4OMTEUR:XS · BBG009Q074Y8

All fundamentals and in-depth analysis of ImExHS

Our stock analysis for ImExHS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImExHS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.